Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Hosted on MSN
48m
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip
Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss ...
53m
on MSN
Doctor reveals alarming new symptom he's seeing in Ozempic patients
Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Israel, Hamas ceasefire deal
Los Angeles wildfire updates
California fires: How to help
Bans use of Red No. 3 dye
‘Cheers’ actor dies at 79
Plans tax hikes on rich
New definition of obesity
Trans sports bill passed
Designates 2 monuments
Announces run for governor
New agency to collect tariffs
FBI erases Chinese malware
MS-13 member guilty
Federal report on alcohol
CA withdraws EPA requests
Stepping down as president
Hit with $100M verdict
Reviews Texas age law
2 lunar landers launched
No federal charges in death
Pam Bondi testifies
SEC sues Elon Musk
Zelenskyy visits Poland
Inflation ticked up to 2.9%
Faces $650M+ DOJ lawsuit
FAA probing near-collision
To lay off 5% of staff
RU missile attack on UKR
Breaks Federer record
Related topics
Eli Lilly and Company
Zepbound
Ozempic
Weight loss
National Health Service
Feedback